Volume | 448,905 |
|
|||||
News | - | ||||||
Day High | 0.1569 | Low High |
|||||
Day Low | 0.1451 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
CytoDyn Inc (QB) | CYDY | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.1569 | 0.1451 | 0.1569 | 0.1476 | 0.151 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
148 | 448,905 | $ 0.149533 | $ 67,126 | - | 0.1275 - 0.418 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
15:59:59 | 119 | $ 0.1476 | USD |
CytoDyn Inc (QB) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
146.93M | 921.12M | 556.02M | 0 | -79.82M | -0.08 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
CytoDyn (QB) News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CYDY Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.138 | 0.1569 | 0.1285 | 0.1421036 | 1,110,691 | 0.0096 | 6.96% |
1 Month | 0.17 | 0.17 | 0.1275 | 0.1476649 | 1,179,073 | -0.0224 | -13.18% |
3 Months | 0.1699 | 0.28 | 0.1275 | 0.1831802 | 2,119,128 | -0.0223 | -13.13% |
6 Months | 0.1601 | 0.418 | 0.1275 | 0.1946324 | 2,662,288 | -0.0125 | -7.81% |
1 Year | 0.274 | 0.418 | 0.1275 | 0.2034754 | 1,996,787 | -0.1264 | -46.13% |
3 Years | 2.72 | 2.99 | 0.1275 | 0.6655618 | 2,185,521 | -2.57 | -94.57% |
5 Years | 0.42 | 10.01 | 0.1275 | 2.17 | 2,877,897 | -0.2724 | -64.86% |
CytoDyn (QB) Description
CytoDyn is a clinical-stage biotechnology company focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells that is believed to play a role in numerous disease processes. CytoDyn is studying leronlimab in multiple therapeutic areas, including infectious disease, cancer, and autoimmune conditions. |